The College offered recommendations on outpatient COVID-19 treatments. Three studies looked at shifts in mortality from COVID-19 at different times and places. An international study compared infections in health care workers with medical masks versus N95s.
29 Nov 2022
Pregnant patients who received monoclonal antibody treatments had no higher risk for adverse obstetric events but also no significant improvement on COVID-19-related outcomes, a retrospective study found.
15 Nov 2022
Two letters reported on SARS-CoV-2 viral rebound among patients taking nirmatrelvir-ritonavir. The latest ACP and Annals of Internal Medicine forum brought experts together to discuss this and other clinical challenges in COVID-19 prevention and management on Wednesday, Sept. 7.
13 Sep 2022
The CDC has recommended the new formulations of the mRNA vaccines, targeted at the BA.4 and BA.5 lineages of the omicron variant, for adults and adolescents who last received a COVID-19 shot at least two months ago.
6 Sep 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum X: Current Clinical Challenges in COVID-19 Prevention and Management
During the Sept. 7 virtual live event, a panel of experts will discuss current methods for preventing and managing SARS-CoV-2 infection.
30 Aug 2022
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
23 Aug 2022
The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
19 Jul 2022
By late May, the rate of prescriptions for molnupiravir and nirmatrelvir/ritonavir was twice as high in the highest-income U.S. ZIP codes as in the lowest, research showed. A CDC webinar on June 28 will discuss efforts to equitably distribute these treatments.
28 Jun 2022
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
21 Jun 2022
A full recording of COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19 is available for replay online.
31 May 2022